Sevelamer Carbonate Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 400 mg , 800mg
Reference Brands: Renvela®
Category:
Nephrology
Sevelamer Carbonate Tablets are non-calcium phosphate binders used in nephrology to manage high phosphate levels in CKD patients on dialysis.
Sevelamer Carbonate Tablets is available in Tablet
and strengths such as 400 mg , 800mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sevelamer Carbonate Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sevelamer Carbonate Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Sevelamer Carbonate Tablets are a leading phosphate binder used to control hyperphosphatemia in chronic kidney disease (CKD) patients undergoing dialysis. Unlike calcium-based binders, Sevelamer carbonate reduces serum phosphate levels without increasing calcium load, minimizing the risk of vascular calcification. It is widely prescribed in nephrology for effective phosphate management in ESRD (end-stage renal disease). Marketed under the brand name Renvela® in the US and EU, Sevelamer Carbonate Tablets are essential for renal care protocols. We offer high-quality, GMP-compliant bulk supply for global Pharma B2B procurement, ideal for hospital tenders, dialysis centers, and private label pharmaceutical companies.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing